The ability to monitor diseases, therapies, and their effects on the body is a critical
component of modern care and personalized medicine. Real time monitoring can be …

Breast implant illness (BII) is a condition characterized by elusive diagnostic criteria and self-
reported diverse disabling and distressing physical and psychological symptoms. With …

ObjectiveA retrospective cross-sectional analysis was conducted of the US Food and Drug
Administration's MAUDE (Manufacturer and User Facility Device Experience) database, to …

Background Despite increasing demand for breast capsular surgery to treat various benign
and malignant implant-related pathologies, high-quality evidence elucidating complication …

The purpose of this article is to review the pivotal events in the history of breast implants in
the United States, including the events leading to the US Food and Drug Administration …

Advances in multi-modality treatments incorporating systemic chemotherapy, endocrine
therapy, and radiotherapy for the management of breast cancer have resulted in a surgical …

Background Although plastic surgeons commonly perform capsulectomies for a variety of
peri-prosthetic capsular conditions, the safety of capsulectomy remains unknown, and the …

Breast implants are widely used after breast cancer resection and must be changed
regularly to avoid a rupture. To date, there are no quantitative criteria to help this decision …

The initiation of veno-venous extracorporeal membrane oxygenation (VV-ECMO) has been
opposed in late-phase acute respiratory distress syndrome (ARDS) due to an increase in …

Objective This article aims to assess the reproducibility of Manufacturer and User Facility
Device Experience (MAUDE) data-driven studies by analyzing the data queries used in their …